Nontuberculous lymphadenitis in children: What management strategy?

被引:16
作者
Gallois, Yohan [1 ]
Cogo, Haude [2 ]
Debuisson, Cecile [2 ]
Guet-Revillet, Helene [3 ]
Brehin, Camille [2 ]
Baladi, Blandine [1 ]
Calmels, Marie-Noelle [1 ]
机构
[1] Ctr Hosp Univ Toulouse, Otoneurol & Pediat ENT Dept, Hop Pierre Paul RIQUET, Toulouse, France
[2] Ctr Hosp Univ Toulouse, Hop Enfants, Gen Pediat Dept, Toulouse, France
[3] Ctr Hosp Univ Toulouse, Hop Pierre Paul RIQUET, Bacteriol & Hyg Dept, Toulouse, France
关键词
Nontuberculous mycobacteria; Cervico-facial lymphadenitis; Antibiotic treatment; Surgery; MYCOBACTERIAL CERVICOFACIAL LYMPHADENITIS; ANTIBIOTIC-TREATMENT; AVIUM COMPLEX; DIAGNOSIS; INFECTIONS; THERAPY; DISEASE; NECK;
D O I
10.1016/j.ijporl.2019.04.012
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Objectives: Nontuberculous mycobacterial (NTM) lymphadenitis is a rare disease of children under 5 years. Its treatment is not standardized, even a "wait-and-see" approach is shown to be effective in the literature. Here, we discuss the diagnostic and therapeutic strategies employed in our departments. Methods: Records of pediatric patients treated for NTM cervical lymphadenitis from 2010 to 2015 in our tertiary center were retrospectively reviewed. Patients underwent cervical echotomography and/or CT scan. Every patient but one had microbiological explorations (NTM polymerase chain reaction [PCR] and culture) on fine needle aspiration of pus and/or adenitis biopsy. Differential diagnoses (tuberculosis, cat scratch disease) were excluded with serologies, chest X-Ray, and PCR on adenitis samples. Patients were classified as "proven diagnosis" (NTM detected), "highly probable" (suggestive clinical and anatomopathological aspect) or "possible" infection (suggestive adenitis alone). Treatments, follow-up and adverse events were reviewed. Results: Thirty-one patients were treated for NTM, median age 2.40 years (Interquartile Range IQR = [1.85-3.16]). Twenty-nine patients (96.77%) had an isolated cervico-facial localization. Median followup was 8.00 months (IQR = [4.20-13.43]). We found 17 "proven diagnosis" (58.62%), 5 "highly probable" (17.24%) and 7 "possible" infections (24.14%). "Proven" infections were due to: Mycobacteritun avium (n = 12, 66.67%) and M. intracellulare (n = 5, 27.78%). All 29 patients received antibiotics, which were effective for 10 (34.48%, group 1); 10 underwent surgical excision for a poor outcome with antibiotics (34.48%, group 2); spontaneous or surgical drainage occurred in 9 on antibiotics (31.03%, group 3). The median times to resolution for group 1, 2 and 3 were respectively 6.33 months, 6.22 months and 9.53 months. Antibiotics treatment was mostly clarithromycin (n = 27, 93.10%) and/or rifampicin (n = 19, 65.52%); 18 patients (62.07%) received both. Median antibiotics duration was 6.23 months (IQR = [5.17-7.46]), with good compliance (79.31%). The observed adverse effects were 3 (13.04%) isolated transient transaminase elevations, 1 case (4.35%) of minor creatinine elevation, and 1 case (4.35%) of transient diarrhea. Surgical drainage caused 1 transient marginal mandibular nerve palsy, resolutive after 1 month. Conclusion: Antibiotics in NTM adenitis lead to resolution in 7 months, with good tolerance and compliance. The efficacy of "wait-and-see" attitude in the literature make excision surgery a second line treatment.
引用
收藏
页码:196 / 202
页数:7
相关论文
共 26 条
[1]  
[Anonymous], MYCOBACTERIUM AVIRUM
[2]   First case of Mycobacterium marseillense lymphadenitis in a child [J].
Azzali, A. ;
Montagnani, C. ;
Simonetti, M. T. ;
Spinelli, G. ;
de Martino, M. ;
Galli, L. .
ITALIAN JOURNAL OF PEDIATRICS, 2017, 43
[3]   AGE-DEPENDENT HUMORAL RESPONSES OF CHILDREN TO MYCOBACTERIAL ANTIGENS [J].
FAIRCHOK, MP ;
ROUSE, JH ;
MORRIS, SL .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1995, 2 (04) :443-447
[4]   Risk factors of non-tuberculous mycobacterial lymphadenitis in children: a case-control study [J].
Garcia-Marcos, Patricia W. ;
Plaza-Fornieles, Mercedes ;
Menasalvas-Ruiz, Ana ;
Ruiz-Pruneda, Ramon ;
Paredes-Reyes, Pedro ;
Miguelez, Santiago Alfayate .
EUROPEAN JOURNAL OF PEDIATRICS, 2017, 176 (05) :607-613
[5]   An official ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases [J].
Griffith, David E. ;
Aksamit, Timothy ;
Brown-Elliott, Barbara A. ;
Catanzaro, Antonino ;
Daley, Charles ;
Gordin, Fred ;
Holland, Steven M. ;
Horsburgh, Robert ;
Huitt, Gwen ;
Iademarco, Michael F. ;
Iseman, Michael ;
Olivier, Kenneth ;
Ruoss, Stephen ;
von Reyn, C. Fordham ;
Wallace, Richard J., Jr. ;
Winthrop, Kevin .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 175 (04) :367-416
[6]   Ethambutol ocular toxicity in treatment regimens for Mycobacterium avium complex lung disease [J].
Griffith, DE ;
Brown-Elliott, BA ;
Shepherd, S ;
McLarty, J ;
Griffith, L ;
Wallace, RJ .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 172 (02) :250-253
[7]   Long-term Follow-up of Observation-Only Management of Nontuberculous Mycobacterial Lymphadenitis [J].
Haimi-Cohen, Yishai ;
Markus-Eidlitz, Tal ;
Amir, Jacob ;
Zeharia, Avraham .
CLINICAL PEDIATRICS, 2016, 55 (12) :1160-1164
[8]   Increase in Childhood Nontuberculous Mycobacterial Infections After Bacille Calmette-Guerin Coverage Drop: A Nationwide, Population-Based Retrospective Study, Finland, 1995-2016 [J].
Kontturi, Antti ;
Soini, Hanna ;
Ollgren, Jukka ;
Salo, Eeva .
CLINICAL INFECTIOUS DISEASES, 2018, 67 (08) :1256-1261
[9]  
LAU SK, 1991, ARCH OTOLARYNGOL, V117, P87
[10]  
LINCOLN EM, 1972, AM REV RESPIR DIS, V105, P683